Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs73197705 | chr13:54336968 | T/C | 1.11E-16 | 174 | 25.6 | 20.42 | 2.3 | KM Plot |
PCPG | rs73197724 | chr13:54424140 | A/G | 1.11E-16 | 175 | 25.67 | 20.12 | 2.3 | KM Plot |
PCPG | rs73200243 | chr21:38444178 | T/G | 9.36E-9 | 176 | 25.08 | 25.87 | 3.83 | KM Plot |
PCPG | rs73201918 | chr21:38455908 | C/T | 1.11E-16 | 172 | 24.85 | 25.4 | 3.17 | KM Plot |
PCPG | rs73201920 | chr21:38455912 | G/T | 9.4E-9 | 176 | 25.08 | 25.63 | 3.83 | KM Plot |
PCPG | rs73201946 | chr21:38478721 | C/A | 9.44E-9 | 175 | 25.35 | 25.87 | 3.83 | KM Plot |
PCPG | rs73204065 | chr21:38558619 | G/C | 9.87E-9 | 176 | 25 | 25.87 | 3.83 | KM Plot |
PCPG | rs73204066 | chr21:38558888 | C/T | 9.76E-9 | 176 | 24.85 | 25.87 | 3.83 | KM Plot |
PCPG | rs7320829 | chr13:114145614 | G/A | 3.64E-12 | 177 | 24.23 | 29.5 | 3.32 | KM Plot |
PCPG | rs7321129 | chr13:37526367 | T/C | 0.000329 | 176 | 4.17 | 24.23 | 25.7 | KM Plot |
PCPG | rs73218601 | chr21:38580808 | T/C | 0 | 176 | 25.08 | 25.87 | 3.17 | KM Plot |
PCPG | rs73220511 | chr21:38601680 | C/T | 1.11E-16 | 174 | 24.7 | 26.57 | 3.17 | KM Plot |
PCPG | rs7322313 | chr13:48410255 | G/A | 6.0E-5 | 178 | 25.4 | 26.18 | 2.93 | KM Plot |
PCPG | rs73236024 | chr12:127830898 | G/C | 0.00039 | 172 | 24.52 | 29.32 | 5.78 | KM Plot |
PCPG | rs73244004 | chr4:40928949 | G/A | 1.19E-5 | 178 | 25.53 | 25.18 | 0.93 | KM Plot |